Please wait...
| ID | PMID | YEAR | Sequence | MAP | Name | C-ter MOD | N-ter MOD | Linear/Cyclic | Stereo-Chemistry | Modified | Length | Fuction | Activity | RBCs Source | Origin | Experimental structure | Non-Hemolytic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17462733 | 2007 | RLKELITTGGQKIGEKIRRIGQRIKDFFKNLQPREEKS | K9CATH | Free | Free | Linear | L | None | 38 | Antimicrobial | 25% hemolysis at 100 μM | Dog | K9CATH canine cathelicidin present in neutorphil granule content | α-helix | NA | ||
| 18752624 | 2008 | MSGIVEAISNAVKSGLDHDWVNMGTSIADVVAKGADFIAGFFS | H1C | Free | Free | Linear | L | None | 43 | Cytotoxic | HD50 =4.37±0.60mM | Dog | Synergistic hemolysins (Staphylococcus cohnii) | NA | NA | ||
| 18752624 | 2008 | MDFIIDIIKKIVGLFTGK | H2C | Free | Free | Linear | L | None | 18 | Cytotoxic | HD50 =5.35±0.60mM | Dog | Synergistic hemolysins (Staphylococcus cohnii) | NA | NA | ||
| 18752624 | 2008 | MSDFVNAISEAVKAGLSADWVTMGTSIADALAKGADFILGFFN | H3C | Free | Free | Linear | L | None | 43 | Cytotoxic | HD50 =1.02±0.04mM | Dog | Synergistic hemolysins (Staphylococcus cohnii) | NA | NA | ||
| 16137634 | 2005 | RQIKIWFQNRRMKWKK{ct:Amid} | pAntp(43–58) | Amidation | Free | Linear | L | None | 16 | CPP | 20.0±1.8% hemolysis at 50µM | Bovine | Penetratin (fragment of Antennapedia homeodomain) | NA | NA | ||
| 16137634 | 2005 | GRKKRRQRRRPPQ{ct:Amid} | pTAT(48–60) | Amidation | Free | Linear | L | None | 13 | CPP | 11.2±1.5% hemolysis at 50µM | Bovine | Fragment of transcription factor coded by theTat protein (HIV virus) | NA | NA | ||
| 16137634 | 2005 | LLIILRRRIRKQAHAHSK{ct:Amid} | pVEC(615–632) | Amidation | Free | Linear | L | None | 18 | CPP | 18.1±0.3% hemolysis at 50µM | Bovine | Vascular endothelial cadherin protein (Murine) | NA | NA | ||
| 16137634 | 2005 | KLALKLALKALKAALKLA{ct:Amid} | MAP | Amidation | Free | Linear | L | None | 18 | CPP | 20.9±1.8% hemolysis at 50µM | Bovine | Synthetic peptide | NA | NA | ||
| 16137634 | 2005 | AGYLLGKINLKALAALAKKIL{ct:Amid} | Transportan 10 | Amidation | Free | Linear | L | None | 21 | CPP | 29.0±4.9% hemolysis at 50µM | Bovine | Galanin and Mastoparan fragments | NA | NA | ||
| 16730859 | 2006 | VTLASHLPSDFTPAVHASLDKFLANVSTVLTSKYR | α107–141 | Free | Free | Linear | L | None | 35 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 16730859 | 2006 | TSKYR | α137–141 | Free | Free | Linear | L | None | 5 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 16730859 | 2006 | STVLTSKYR | α133–141 | Free | Free | Linear | L | None | 9 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 16730859 | 2006 | VTLASHLPSDFTPAVHASLDKFLANVSTVL | a107–136 | Free | Free | Linear | L | None | 30 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 16730859 | 2006 | QADFQKVVAGVANALAHRYH | β126-145 | Free | Free | Linear | L | None | 20 | Antibacterial | Non-hemolytic | Bovine | Bovine hemoglobin | NA | Non-hemolytic | ||
| 11226440 | 2001 | VLSAADKGNVKAAWGKVGGHAAE | α 1-23 peptide | Free | Free | Linear | L | None | 23 | Antibacterial | 0% hemolysis upto 2.013 mM (non-hemolytic) | Bovine | Peptic bovine hemoglobin hydrolysate | NA | Non-hemolytic | ||
| 22858580 | 2013 | MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLR | cgUbiquitin | Free | Free | Linear | L | None | 74 | Antimicrobial | 0% hemolytic at 100μg/ml (non-hemolytic) | Hagfish | Ubiquitin (Crassostrea gigas) | NA | Non-hemolytic | ||
| 9026036 | 1997 | CIGAVLKVLTTGLPALISWIKRKRQQ | Dioleoylmelittin | Free | Free | Linear | L | None | 26 | Membrane disturbing | ~20% hemolysis at 1μM | Dog | Synthetic peptide | NA | NA | ||
| 9026036 | 1997 | CIGAVLKVLTTGLPALISWIKRKRQQ | Dioleoylmelittin | Free | Free | Linear | L | None | 26 | Membrane disturbing | 100% hemolysis at 10μM | Dog | Synthetic peptide | NA | NA | ||
| 10600529 | 1999 | RHARHD | Hannahpep | Free | Free | Linear | L | None | 6 | Plasma-anticlotting | No hemolysis (non hemolytic) | Goat | Indian King Cobra (Ophiophagus hannah) Venom | NA | Non-hemolytic | ||
| 12969798 | 2004 | KAVAAKKSPKKAKKPAT | Oncorhyncin II | Free | Free | Linear | L | None | 17 | Antimicrobial | No hemolysis at 0.8μM(non hemolytic) | Trout | Oncorhyncin II (acid extract of rainbow trout skin secretion Oncorhynchus mykiss) | NA | Non-hemolytic | ||
| 9204560 | 1997 | F{d}R{d}L{d}K{d}F{d}H{d} | 66-10 | Free | Free | Linear | D | None | 6 | Antimicrobial | 0% hemolysis at 312 to 0μg/ml | Bovine | Synthetic Peptide | NA | Non-hemolytic | ||
| 9204560 | 1997 | F{d}R{d}L{d}K{d}F{d}H{d} | 66-10 | Free | Free | Linear | D | None | 6 | Antimicrobial | 0% hemolysis at 312 to 0μg/ml | Ovine | Synthetic Peptide | NA | Non-hemolytic | ||
| 16137634 | 2005 | INLKALAALAKALL{ct:Amid} | Mastoparan 7 | Amidation | Free | Linear | L | None | 14 | Antimicrobial | 100 % hemolysis at 25 µM | Bovine | Mastoparan analogs | NA | NA | ||
| 25966444 | 2015 | Q(L)R{nt:C18-aliphatic chain}{ct:Amid} | LP1 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 3 | Antibacterial | 50 % Hemolysis at >100 µM | Bovine | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | QLR{nt:C18-aliphatic chain}{ct:Amid} | LP2 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 3 | Antibacterial | 50 % Hemolysis at >100 µM | Bovine | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | CGCQ(L)R{nt:C18-aliphatic chain}{ct:Amid} | LP3 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 6 | Antibacterial | 50 % Hemolysis at >100 µM | Bovine | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | CGCQLR{nt:C18-aliphatic chain}{ct:Amid} | LP4 | Amidation | C18-aliphatic chain | Linear | L | C18 = aliphatic chain | 6 | Antibacterial | 50 % Hemolysis at >100 µM | Bovine | Host Defence Peptides | α-Helix | NA | ||
| 25966444 | 2015 | {nnr:βA}{nnr:βA}KIAKLKAKIQKLKQKIAKLK{nt:C12-aliphatic chain}{ct:Amid} | LH | Amidation | C12-aliphatic domain,βA- 2 spacer | Linear | L | C12 = aliphatic domain, βA = 2 spacer | 22 | Antibacterial | 50 % Hemolysis at >100 µM | Bovine | Host Defence Peptides | α-Helix | NA | ||
| 28559266 | 2017 | VRLIVAVRIWRR{ct:Amid} | IDR-1018 | Amidation | Free | Linear | L | None | 12 | Antifungal, Antibiofilm | 2.3 - 3.3 % Hemolysis at 32-128 μg/ml | Murine | Variant Of Bovine Hdp Bac2A | NA | NA | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 6.25 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 12.5 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 25 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 0 % Hemolysis at 50 μg/mL | Murine | Original Octominin | Random coil | Non-hemolytic | ||
| 37762357 | 2023 | GWLIRGAIHAGKAIHGLI | Octominin II | Free | Free | Linear | L | None | 23 | Antimicrobial | 10 % Hemolysis at 100 μg/mL | Murine | Original Octominin | Random coil | NA | ||
| 37768945 | 2023 | QRSVSNAATRVCRTGRSRWRDVCRNFMRR{nt:Acet}{ct:Amid} | Human granulysin (hGRNL) | Amidation | acetylation | Linear | L | None | 29 | Antimicrobial | 0 % Hemolysis at 0.39-50 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.8 % Hemolysis at 50 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.8 % Hemolysis at 25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 12.5 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 6.25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 3.12 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.8 % Hemolysis at 1.56 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 0.78 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR{nt:Acet}{ct:Amid} | bovine NKlysin NK2A (bNK2A) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 0.39 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <1.6 % Hemolysis at 50 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | ~0.4 % Hemolysis at 25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0.4 % Hemolysis at 12.5 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 6.25 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | <0.4 % Hemolysis at 3.12 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 1.56 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 0.78 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 37768945 | 2023 | TVTQAASRVCDKMKILRGVCKKIMRTFLRR{nt:Acet}{ct:Amid} | porcine NKlysin (pNKL) | Amidation | acetylation | Linear | L | None | 30 | Antimicrobial | 0 % Hemolysis at 0.39 µM | Cattle | Synthetic | Disordered | Non-hemolytic | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSLFQRKKE | Meucin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 50 % Hemolysis at 25 μM | Lizard | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSFFRRKNQ | Marcin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 99 % Hemolysis at 25 μM | Lizard | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFK{ct:Amid} | MeuFSPL-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 99 % Hemolysis at 25 μM | Lizard | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFKGRRKRDLN{ct:Amid} | Marmelittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 99 % Hemolysis at 25 μM | Lizard | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSLFQRKKE | Meucin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 45 % Hemolysis at 25 μM | Pigeons | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FFGHLFKLATKIIPSFFRRKNQ | Marcin-22 | Free | Free | Linear | L | None | 22 | Antimicrobial | 40 % Hemolysis at 25 μM | Pigeons | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFK{ct:Amid} | MeuFSPL-1 | Amidation | Free | Linear | L | None | 18 | Antimicrobial | 40 % Hemolysis at 25 μM | Pigeons | Mesobuthus Eupeus Scorpion Species | α-Helical | NA | ||
| 29599756 | 2018 | FLFSLIPSAISGLISAFKGRRKRDLN{ct:Amid} | Marmelittin | Amidation | Free | Linear | L | None | 26 | Antimicrobial | 100 % Hemolysis at 25 μM | Pigeons | Mesobuthus Martensii Scorpion Species | α-Helical | NA | ||
| 29670183 | 2018 | IITHPNFNGNTLDNDIMLIK | Lunathrombase | Free | Free | Linear | L | None | 20 | Anticoagulant, in-vitro thrombolytic activity, Antiplatelet | 7.65 ± 0.53(m/mm3) % Hemolysis at 10 mg/kg | Goat | Serine Protease From Leaves Of Leucas Indica Plant | e CD spectrum of lunathrombase demonstrated that it consists of 23.4% α-Helix, 17% Beta Sheets, with a Turn of 28.2% and 31% Random coils | Non-hemolytic | ||
| 31216348 | 2019 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR | bNK2A-C10C20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 5 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 31216348 | 2019 | TVIEVASKMSSKMRLLKGLSKSITKRFLRR | bNK2A-S10S20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 5 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 31216348 | 2019 | TVIEVASKMCSKMRLLKGLCKSITKRFLRR | bNK2A-C10C20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 20 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 31216348 | 2019 | TVIEVASKMSSKMRLLKGLSKSITKRFLRR | bNK2A-S10S20 | Free | Free | Linear | L | None | 30 | Antibacterial | <2 % Hemolysis at 20 μM | Cattle | Nk-Lysin-Derived Peptides | TFE = α-Helix, NaPB = Random coil | Non-hemolytic | ||
| 31520928 | 2019 | YEIKINRHFKTLKKNLKK{ct:Amid} | H5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | Bighead Carp Aristicluthys Nobilia Ifn-I | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKINRHFKTLKKNLKK{ct:Amid} | P1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKTLNKNLKK{ct:Amid} | P2 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLNKNLKK{ct:Amid} | P3 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YFRTIRRFFKKLFKTLKK{ct:Amid} | P4 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 640 µg/ml | Murine | H5-Derived Peptides | MME = α‐Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLKKILKK{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 10 % Hemolysis at 640 µg/ml | Murine | H5-Derived Peptides | Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKRFKFRKK{ct:Amid} | P6 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WVRKVRRWWKKVKKVVKK{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 10 % Hemolysis at 80.04 ± 7.2 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | NA | ||
| 31520928 | 2019 | SYEIKINRHFKTLKKNLKKK{ct:Amid} | P8 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | SYERKINRHFKTLKKNLKKK{ct:Amid} | P9 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WYERLINRKFKWLKGRLSKK{ct:Amid} | P10 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 178.82 ± 12.6 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | NA | ||
| 31520928 | 2019 | LYKRYILRKFKFLKKKLKKK{ct:Amid} | P11 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | VWKRWVVRKWKWVKKKVKKK{ct:Amid} | P12 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 10 % Hemolysis at 57.24 ± 5.2 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | NA | ||
| 31520928 | 2019 | YEIKINRHFKTLKKNLKK{ct:Amid} | H5 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | Bighead Carp Aristicluthys Nobilia Ifn-I | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKINRHFKTLKKNLKK{ct:Amid} | P1 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKTLNKNLKK{ct:Amid} | P2 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLNKNLKK{ct:Amid} | P3 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | YFRTIRRFFKKLFKTLKK{ct:Amid} | P4 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = α‐Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKLKKILKK{ct:Amid} | P5 | Amidation | Free | Linear | L | None | 18 | Antibacterial, Antibiofilm | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | Helical | Low hemolytic | ||
| 31520928 | 2019 | YIRKIRRFFKKRFKFRKK{ct:Amid} | P6 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WVRKVRRWWKKVKKVVKK{ct:Amid} | P7 | Amidation | Free | Linear | L | None | 18 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | Low hemolytic | ||
| 31520928 | 2019 | SYEIKINRHFKTLKKNLKKK{ct:Amid} | P8 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | SYERKINRHFKTLKKNLKKK{ct:Amid} | P9 | Amidation | Free | Linear | L | None | 20 | Antibacterial, Antibiofilm | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | WYERLINRKFKWLKGRLSKK{ct:Amid} | P10 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | Low hemolytic | ||
| 31520928 | 2019 | LYKRYILRKFKFLKKKLKKK{ct:Amid} | P11 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | NA | Low hemolytic | ||
| 31520928 | 2019 | VWKRWVVRKWKWVKKKVKKK{ct:Amid} | P12 | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at >640 µg/ml | Murine | H5-Derived Peptides | MME = β-Turn | Low hemolytic | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal-)Ala} | 1 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial, Anticancer | 19.7 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Bu)Gly}-K-K-K | 2 | Free | Free | Linear | L | (N-Phe)Gly = N-benzylglycine, (N1-Nal)Gly = N-1-naphthylmethylglycine, (N-Bu)Gly = N-butylglycine | 7 | Antibacterial, Anticancer | 100.1 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K | 3 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 10.5 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K | 4 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K | 5 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial, Anticancer | 22.5 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 6 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 101.2 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(1-Nal)Ala}-F{nnr:(1-Nal)Ala} | 7 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 102.1 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K | 8 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 25.8 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K | 9 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 25.5 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 10 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 36.3 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 11 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | 40.7 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala} | 12 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | 50.2 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-K-L-K-K | 13 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 27.4 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-{nnr:(N-Bu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 14 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial | 28.1 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:(N-Bu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 15 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial, Anticancer | 87.1 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K | 16 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 27.7 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 17 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 100 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 18 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | 100.7 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-Leu{nnr:(1-Nal)Ala}-Y-{nnr:(1-Nal)Ala} | 19 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 100.8 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 20 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine, Nle= norleucine | 7 | Antibacterial | 36 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala} | 21 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, y = D-Tyr | 7 | Antibacterial | 19.9 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 22 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | 83 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:N-Lys}-{nnr:N-Lys}-{nnr:N-Lys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 23 | Free | Free | Linear | L | N-Lys = N-(4-aminobutyl)glycine, (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 35.1 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala} | 24 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu | 7 | Antibacterial | 38.5 % Hemolysis at 150 µM | Canine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal-)Ala} | 1 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial, Anticancer | 32.5 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Bu)Gly}-K-K-K | 2 | Free | Free | Linear | L | (N-Phe)Gly = N-benzylglycine, (N1-Nal)Gly = N-1-naphthylmethylglycine, (N-Bu)Gly = N-butylglycine | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-K-L{d}-K-K | 3 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala}-L{d}-K-K-K | 4 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-L-K-K-K | 5 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-L-K-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 6 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 39.9 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(1-Nal)Ala}-F{nnr:(1-Nal)Ala} | 7 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 16 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-K-L{d}-K-K | 8 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala}-L{d}-K-K-K | 9 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-L{d}-K-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 10 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(1-nal)ala}-F{d}-{nnr:(1-nal)ala} | 11 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial, Anticancer | 17.4 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-F{d}-{nnr:(2-nal)ala} | 12 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanin, f = D-phenylalanine, l = D-Leu | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala}-K-L-K-K | 13 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 17.6 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-{nnr:(N-Bu)Gly}-K-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 14 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial | 13.9 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:(N-Bu)Gly}-{nnr:(N1-Nal)Gly}-{nnr:(N-Phe)Gly}-{nnr:(N1-Nal)Gly} | 15 | Free | Free | Linear | L | (N-Bu)Gly = N-butylglycine, (N1-Nal)Gly = N-1-napthylmethylglycine, (N-Phe)Gly = N-benyzylglycine | 7 | Antibacterial, Anticancer | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala}-K-L-K-K | 16 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | 30.6 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 17 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 19.9 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 18 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-K-Leu{nnr:(1-Nal)Ala}-Y-{nnr:(1-Nal)Ala} | 19 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(1-Nal)Ala}-F-{nnr:(1-Nal)Ala} | 20 | Free | Free | Linear | L | (1-Nal)Ala = 1-napthylalanine, Nle= norleucine | 7 | Antibacterial | 20.1 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-l--{nnr:(1-nal)ala}-Y{d}-{nnr:(1-nal)ala} | 21 | Free | Free | Linear | Mix | (1-nal)ala = D-1-napthylalanine, y = D-Tyr | 7 | Antibacterial | 16 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-{nnr:Nle}-{nnr:(2-Nal)Ala}-Y-{nnr:(2-Nal)Ala} | 22 | Free | Free | Linear | L | (2-Nal)Ala = 2-napthylalanine, Nle= norleucine | 7 | Antibacterial | <8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | Low hemolytic | ||
| 32764602 | 2020 | {nnr:N-Lys}-{nnr:N-Lys}-{nnr:N-Lys}-L-{nnr:(2-Nal)Ala}-F-{nnr:(2-Nal)Ala} | 23 | Free | Free | Linear | L | N-Lys = N-(4-aminobutyl)glycine, (2-Nal)Ala = 2-napthylalanine | 7 | Antibacterial | 11.1 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 32764602 | 2020 | K-K-K-L{d}-{nnr:(2-nal)ala}-Y{d}-{nnr:(2-nal)ala} | 24 | Free | Free | Linear | Mix | (2-nal)ala = D-2-napthylalanine, y = D-Tyr, l = D-Leu | 7 | Antibacterial | 29.8 % Hemolysis at 150 µM | Bovine | Synthetic Amps | NA | NA | ||
| 33175275 | 2020 | AFALIAGALYRIFHRR | LHH1 | Free | Free | Linear | L | None | 16 | Antibacterial | 50 % Hemolysis at 187.2 μM | Goat | Lactobacillus Casei Hz1 | water = Random coil, 50% TFE and 30 mM SDS = α-Helical | Low hemolytic | ||
| 33218175 | 2020 | LVDIYTHVYNCTSSEKHTHCYEIRKSIS | OrR214 | Free | Free | Linear | L | None | 28 | Antibacterial | 0.142 % Hemolysis at 150 μM | Goat | Plant Oryza Rufipogon Griff | α-Helix Random coil | Non-hemolytic | ||
| 33218175 | 2020 | LGVPVSSTLRLNNTTMNPCLPS | OrR935 | Free | Free | Linear | L | None | 22 | Antibacterial | 0.306 % Hemolysis at 150 μM | Goat | Plant Oryza Rufipogon Griff | Random coil | Non-hemolytic | ||
| 33920239 | 2021 | GANAAKKFATIAKKFINYLW | GW-Q4 | Free | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 128 μg/ml | NA | Synthetic Peptide | NA | NA | ||
| 33920239 | 2021 | GANAAKKFATIAKKFINYLW{ct:Amid} | GW-Q4a | Amidation | Free | Linear | L | None | 20 | Antibacterial | 50 % Hemolysis at 32 μg/ml | NA | Analogs Gw-Q4 | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINYLW | Q4-15 | Free | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 128 μg/ml | NA | Derived From Truncation Of Gw-Q4 | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINYLW{ct:Amid} | Q4-15a | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 16 μg/ml | NA | C-Terminal Amide Derivative Of Q4-15 | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINKLW | Q4-15-1 | Free | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 256 μg/ml | NA | Derived From Q4-15 With A Substitution | NA | Low hemolytic | ||
| 33920239 | 2021 | KKFATIAKKFINKLW{ct:Amid} | Q4-15a-1 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 256 μg/ml | NA | C-Terminal Amide Derivative Of Q4-15-1 | NA | Low hemolytic | ||
| 33920239 | 2021 | KKFATIAKKFINWLW | Q4-15-2 | Free | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 32 μg/ml | NA | Derived From Q4-15 With A Substitution | NA | NA | ||
| 33920239 | 2021 | KKFATIAKKFINWLW{ct:Amid} | Q4-15a-2 | Amidation | Free | Linear | L | None | 15 | Antibacterial | 50 % Hemolysis at 16 μg/ml | NA | C-Terminal Amide Derivative Of Q4-15-2 | NA | NA | ||
| 35720462 | 2022 | MHHHHHHGVIPGECIALKGVCRDKICSTLDDTIGICNEGKKCORRWWILEPYPIPVPKGKSP | human β-defensin 130 (hBD130) | Free | Free | Linear | L | None | 63 | Antimicrobial | 1.2 % Hemolysis at 400 µg/mL | Murine | Human | NA | Low hemolytic | ||
| 35835842 | 2022 | RFGRFLRKIRRFRPK | N-15 Cath-2 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 97.76 μg/mL | Murine | N-Terminal Fragment Of Chicken Cathelicidin-2 | α-Helix | NA | ||
| 35835842 | 2022 | RFGRFLRKILRFLKK | DP1 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 216 μg/mL | Murine | Synthetic; N-15 Cath-2 Analogs | α-Helix | NA | ||
| 35835842 | 2022 | RFGRFLRKILRFLRK | DP2 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 145 μg/mL | Murine | Synthetic; N-15 Cath-2 Analogs | α-Helix | NA | ||
| 35835842 | 2022 | RFGRFLRKILRFLLK | DP3 | Free | Free | Linear | L | None | 15 | Antimicrobial | 50 % Hemolysis at 24.62 μg/mL | Murine | Synthetic | α-Helix | NA | ||
| 36109567 | 2022 | LLKELWTKMKGAGKAVLGKIKGLL | Bm-ponericin-L1 | Free | Free | Linear | L | None | 24 | Antimicrobial | 0.2 % Hemolysis | Bovine | Bombyx Mori | α-Helix | Non-hemolytic | ||
| 26335363 | 2015 | MTFLILTILATVTPSLYSHVVQRELRVNFEPLAGQRDSWPVARAAMVTFDARSEKAREFSECRMINSMHELSRELMDSPEHTVKRASKEEMDDLVQRCSGSAEGRSWFIWPDTKWCGPGTDAKNESDLGPLEADKCCRTHDHCDYIGAGETKYGLTNKSFFTKLNCKCEAAFDQCLKESIDRAEGSAKSSMEGLHSFYFNTYSPECYEVKCSRKRDAECTNGIAIWKDSYKS | Phospholipase A2 hemilipin (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase) (Phospholipase A(2)) [Cleaved into: Phospholipase A2 large subunit; Phospholipase A2 small subunit] | Free | Free | Linear | L | None | 232 | Antimicrobial | Hemolytic | NA | Hemiscorpius Lepturus (Scorpion) | NA | NA | ||
| 28335389 | 2017 | MAHCYYNSKRGCNRVMKTVALVVLISTVMVEESRGDSQEDKKRPIWNIGHMVNAVKQIEEFLDLGANALEADVTFDDNGNPKWTYHGTPCDCFRDCLRWEYVDEYLKRIRELTSPGSSKFRKGFILLMLDLKISKLSDNAKSKAGKEIADMIIKRLWSGSGEKAQLYIVLSFPYVNDIEFVRAFRERVKSKGFASEAEKRIGWDISGNEDLGKIRDAYQKLGITDNVWQSDGITNCLTRSHDRLAEAVCKRDSDKEWPSLKKVYYWTVDKQSSMKEALKVGVDGMITNDPDDLVAVLNEFSGTHRLANINDSPWQKIPRPKSNC | Dermonecrotic toxin Hl-PLD1 (EC 4.6.1.-) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D) (SMD) (SMase D) (Sphingomyelinase D) | Free | Free | Linear | L | None | 324 | Antimicrobial | Hemolytic | NA | Hemiscorpius Lepturus (Scorpion) | NA | NA | ||
| 29900074 | 2018 | MNVFFMFSLVFLAAFGSCADDTRPLGECFREADYEEFLEIARNGLKKTSNPKHVVVVGAGMSGLSAAYVLAKAGHKVTLLEASEGVGGRVKTYRNKQEGWYINLGPMRLPERHRIVREYIRKFHLPLSEFVQENENTWYYIKNIRKRVSEVKKNPDLFEYPVNPSEKGKSASQLYQESLEKVIDELKRTNCNHILNKYDTYSTKEYLIKEGNLSPGAVDMIGDLLNEDSSFYLSFIESLKSDDIFSYEKRFDEIVGGFDQLPISMYQAIAEMVHLNAQVIKIQHNAKKVIVTYQTPAKTLPSVTADYVIVCSTSRAARHIRFQPPLPTNKARALRSIHYRSAIKIFLTCTKRFWEADGIHGGKSTTDLPSRFIYYFNQNFTNGIGVIMAYVLADDAKFFQPHDLKTNADIVINDLSLIHQLPKEEIQALCRPSWIQKWSLDKYAMGSITSFTPYQFLDYFEIAAAPVGRIHFAGEYTAKHHGWIDSTIKSGLRAARDVNRA | L-amino acid oxidase (LAO) (MipLAAO1) (EC 1.4.3.2) | Free | Free | Linear | L | None | 501 | Antibiotic;Antimicrobial | Hemolytic | NA | Micrurus Mipartitus (Red-Tailed Coral Snake) | NA | NA | ||
| 19393676 | 2009 | MNVFSIFSLVFLAAFGSCADDRRSALEECFREADYEEFLEIARNGLKKTSNPKHVVVVGAGMAGLSAAYVLAGAGHRVTLLEASDRVGGRVNTYRDEKEGWYVNMGPMRLPERHRIVRTYIAKFGLKLNEFFQENENAWYFIRNIRKRVWEVKKDPGVFKYPVKPSEEGKSASQLYRESLKKVIEELKRTNCSYILDKYDTYSTKEYLIKEGNLSRGAVDMIGDLLNEDSSYYLSFIESLKNDDLFSYEKRFDEISDGFDQLPKSMHQAIAEMVHLNAQVIKIQRDAEKVRVAYQTPAKTLSYVTADYVIVCATSRAVRRISFEPPLPPKKAHALRSIHYKSATKIFLTCTRKFWEADGIHGGKSTTDLPSRFIYYPNHNFTSGVGVIVAYVLADDSDFFQALDIKTSADIVINDLSLIHQLPKNEIQALCYPSLIKKWSLDKYTMGALTSFTPYQFQDYIETVAAPVGRIYFAGEYTATVHGWLDSTIKSGLTAARNVNRASQKPSRIHLINDNQL | L-amino-acid oxidase (Bf-LAAO) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 517 | Antibiotic;Antimicrobial | Hemolytic | NA | Bungarus Fasciatus (Banded Krait) (Pseudoboa Fasciata) | NA | NA | ||
| 22480909 | 2012 | MNVFFMFSLLFLAALGSCADDGNPLEECFRETDYEEFLEIAKNGLSATSNPKHVVIVGAGMSGLSAAYVLANAGHQVTVLEASKRAGGRVRTYRNDKEGWYANLGPMRLPEKHRIVREYIRKFGLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLEYPVKPSEVGKSAGQLYEESLQKAVEELRRTNCSYMLNKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDKLPTSMYQAIQEKVRLNVRVIKIQQDVKEVTVTYQTSAKETLSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFIYYPNHNFPSGVGVIIAYGIGDDANFFQALDFKDCGDIVINDLSLIHQLPKEEIQAFCRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIDSTIKSGLTAARDVNRASE | L-amino-acid oxidase (Bp-LAAO) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 503 | Antibiotic;Antimicrobial | High Hemolytic | NA | Bothrops Pauloensis (Neuwied'S Lancehead) (Bothrops Neuwiedi Pauloensis) | NA | NA | ||
| 26273287 | 2015 | MNVFFMFSLLFLAALGSCAHDRNPLEECFRETDYEEFLEIARNGLTVTSNPKHVVIVGAGMAGLSAAYVLAGAGHQVTVLEASERVGGRVRTYRKKDWYANLGPMRLPTKHRIVREYIRKFGLQLNEFFQENENAWYFIKNIRKRVREVKNNPGILEYPVKPSEEGKSAAQLYVESLRKVVKELKRTNCKYILDKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFGYEKRFDEIVGGMDQLPTSMYEAIKEKVQVHFNARVIEIQQNDRETKVTYQTSANEMSSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCKRKFWEDDGIRGGKSTTDLPSRFIYYPNHNFTSGVGVIIAYGIGDDANFFQALDFKDCADIVINDLSLIHQLPKEDIQTFCRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPFKRIYFAGEYTAQFHGWIDSTIKSGLTAARDVNRASENPSGIHLSNDNEF | L-amino acid oxidase bordonein-L (LAAO) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 516 | Antibiotic;Antimicrobial | Hemolytic | NA | Crotalus Durissus Terrificus (South American Rattlesnake) | NA | NA | ||
| 12760418 | 2002 | ADNRRPIWVMGHMVNSLAQIDEFVNLGANSIETDVSFDRNCQVLVVFDLKTGHRWQFGGITNKVLNEAAYK | Dermonecrotic toxin LgSicTox-alphaI-Loxn-A (EC 4.6.1.-) (Loxnecrogin-A) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D) (SMD) (SMase D) (Sphingomyelinase D) | Free | Free | Linear | L | None | 71 | Toxic | Hemolytic | NA | Loxosceles Gaucho (Spider) | NA | NA | ||
| 16828829 | 2006 | ADDKNPLEECFREDDYEEFLEIAKNGLEGWYANLGPMRYPVKPSEEGKHDDIFAYEKFDEIVGGMDKKFWEDDGIHGGKETFCYSPMIQKPYQFQHFSEALTAPVGR | L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 107 | Antimicrobial | Hemolytic | NA | Macrovipera Lebetinus (Levantine Viper) (Vipera Lebetina) | NA | NA | ||
| 19944711 | 2010 | AHDGNPLEECFREDDEEFFLEIAKNGLTATSNPKRVVIV{ct:Amid} | L-amino-acid oxidase (BmarLAAO) (LAO) (EC 1.4.3.2) | Amidation | Free | Linear | L | None | 39 | Antibacterial and Antiparasitic | Hemolytic | NA | Bothrops Marajoensis (Marajo Lancehead) | NA | NA | ||
| 15142548 | 2004 | ADVRNPLEEFRETDYEVL | L-amino-acid oxidase (Balt-LAAO-I) (LAO) (EC 1.4.3.2) | Free | Free | Linear | L | None | 18 | Antibacterial | Hemolytic | NA | Bothrops Alternatus (Urutu) (Rhinocerophis Alternatus) | NA | NA | ||
| 2693022 | 1989 | MSKITLSSLKSSLQQGLKNGKNKLNQAGTTLKNGLTQTGHSLQNGAKKLILYIPQGYDSGQGNGVQDLVKAANDLGIEVWREERSNLDIAKTSFDTTQKILGFTDRGIVLFAPQLDNLLKKNPKIGNTLGSASSISQNIGKANTVLGGIQSILGSVLSGVNLNELLQNKDPNQLELAKAGLELTNELVGNIASSVQTVDAFAEQISKLGSHLQNVKGLGGLSNKLQNLPDLGKASLGLDIISGLLSGASAGLILADKEASTEKKAAAGVEFANQIIGNVTKAVSSYILAQRVASGLSSTGPVAALIASTVALAVSPLSFLNVADKFKQADLIKSYSERFQKLGYDGDRLLADFHRETGTIDASVTTINTALAAISGGVGAASAGSLVGAPVALLVAGVTGLITTILEYSKQAMFEHVANKVHDRIVEWEKKHNKNYFEQGYDSRHLADLQDNMKFLINLNKELQAERVVAITQQRWDNQIGDLAAISRRTDKISSGKAYVDAFEEGQHQSYDSSVQLDNKNGIINISNTNRKTQSVLFRTPLLTPGEENRERIQEGKNSYITKLHIQRVDSWTVTDGDASSSVDFTNVVQRIAVKFDDAGNIIESKDTKIIANLGAGNDNVFVGSSTTVIDGGDGHDRVHYSRGEYGALVIDATAETEKGSYSVKRYVGDSKALHETIATHQTNVGNREEKIEYRREDDRFHTGYTVTDSLKSVEEIIGSQFNDIFKGSQFDDVFHGGNGVDTIDGNDGDDHLFGGAGDDVIDGGNGNNFLVGGTGNDIISGGKDNDIYVHKTGDGNDSITDSGGQDKLAFSDVNLKDLTFKKVDSSLEIINQKGEKVRIGNWFLEDDLASTVANYKATNDRKIEEIIGKGGERITSEQVDKLIKEGNNQISAEALSKVVNDYNTSKDRQNVSNSLAKLISSVGSFTSSSDFRNNLGTYVPSSIDVSNNIQLARAA | RTX-II toxin determinant A (APX-IIA) (Cytolysin IIA) (CLY-IIA) (Hemolysin IIA) (HLY-IIA) | Free | Free | Linear | L | None | 956 | Antisera | Hemolytic | goat | Actinobacillus Pleuropneumoniae (Haemophilus Pleuropneumoniae) | NA | Low hemolytic | ||
| 12372834 | 2002 | MNFYKYLVVLVVLVLCLSATQTEARGFRKHFNKLVKKVKHTISETAHVAKDTAVIAGSGAAVVAATG{ct:Amid} | Stomoxyn | Amidation | Free | Linear | L | None | 67 | Antimicrobial | <4 % Hemolytic at 10µM | Bovine | Stomoxys Calcitrans (Stable Fly) (Conops Calcitrans) | Helix | NA | ||
| 12657318 | 2003 | GWPAYPGPNGIRSSVCQTKLGCGKKNLATKGVCKAFCLGRKRFWQKCGKNGSSGKGSRICNPVLAHAVEKAGKGLIKVTDMAVAAIVKYAGKK | Parbolysin P4 (Parbolysin 4) | Free | Free | Linear | L | None | 93 | Cytolysis | 50 % Hemolytic at 5.75μg/ml | Bovine | Parborlasia Corrugatus (Antarctic Nemertean Worm) | NA | NA |